Cancer Market Research Reports & Industry Analysis
Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
... presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know ...
Aug, 2018 104 pages... Novel Drug Delivery Systems (NDDS) in Cancer Therapy market size will grow from XX Million in 2017 to XX Million by 2023 ... , and the market size is projected from 2018 to 2023. The world is witnessing a continuous rise ... detail. Data and information by manufacturer, by region, by type, by application and etc, and ...
Aug, 2018 153 pages... to the growth of the global market for in-vitro colorectal cancer screening testing. By Market Players: Abbott ... 2012 to 2017 and forecast data from 2018 to 2023. The growth factors of the market is ... explained in detail. Data and information by manufacturer, by region, by type, by application and etc, and custom ...
Aug, 2018 157 pages... , and the market size is projected from 2018 to 2023. According to the World Health Organization (WHO), cervical cancer is the second most commonly prevalent ... of the market are explained in detail. Data and information by manufacturer, by region, by type, by application and etc, and custom research can be added ...
Aug, 2018 131 pages... . MARKET SEGMENTATION: Global Cancer gene therapy market is segmented on the basis of regional outlook and following segments: Global Cancer gene therapy Market Research and Analysis, By Therapy Global Cancer gene therapy Market Research and Analysis, By End Users Global Cancer gene therapy Market Research ...
Jul, 2018Pancreatic Cancer: Opportunity Analysis and Forecast to 2026 SUMMARY Pancreatic cancer is set to become the second leading cause of cancer-related deaths in the US in 2020 after lung cancer ... and implications for the pancreatic cancer therapeutics market. Pipeline analysis: comprehensive data assessing emerging ...
Apr, 2018 225 pagesReport Package Immuno-Oncology: Inhibitory and Stimulatory Immunomodulators This product consists of four reports in pdf ... include compilations of currently active projects in research and development of immunomodulators in immuno-oncology. In addition, each report lists company-specific R&D pipelines of ...
Jul, 2018 455 pages... -1401) of Takara Bio. Products covered by Phase Phase III, Phase II, Phase I IND Pre-clinical & Discovery Inactive Overview of pipeline development activities for Oncolytic Virus Cancer Therapy Pipeline analysis of therapeutic drugs include but are not ...
Jul, 2018 200 pages... , and Rocapuldencel-T of Argos Therapeutics. Products covered by Phase Phase III, Phase II, Phase I IND Pre-clinical & Discovery Inactive (Dormant & Discontinued) Overview of pipeline development activities for Dendritic Cancer Cell Therapy Pipeline analysis of therapeutic drugs include but are ...
Jul, 2018 160 pages... Tests are divided into Occult blood and DNA tests. Colorectal cancer diagnostic market is expected to grow in future due to increasing disposable ... quality of screening process and dearth of expertise. The report “Colorectal Cancer Diagnostics Market with Focus on DNA-based Tests: Industry Analysis & Outlook ( ...
Jul, 2018 86 pagesThe global colorectal cancer (CRC) drugs market size is expected to reach ... some of the unmet needs of the colorectal cancer (CRC) market. If approved, Array Biopharma’s ... drugs Roche led the colorectal cancer industrial setting in 2016 due to growing usage of Avastin. Avastin was the highest revenue-generating CRC ...
Jun, 2018 99 pagesThe global liver cancer drugs market size is expected to be valued at USD 1.47 billion by 2022, as per a new report by Grand ... of 19.4% during the forecast period. The growth of liver cancer market is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rising public ...
Jun, 2018 92 pages... kidney cancer drugs market size is expected to be valued at USD 6.3 billion by 2022, as per a new report by Grand View Research, Inc., registering a CAGR of 5.4% during the forecast period. Market ... hand, surge in kidney cancer screening is a key driver in markets such as EU Emerging markets in Asia Pacific and ...
Jun, 2018 99 pages... North America’s country (United State and Canada) which provides a complete country-wise analysis of North America Cervical Cancer Screening Market, Population and Mortality. Cervical Cancer Diagnostic Market & Population Pap Smear Tests Market HPV DNA Tests Market Cervical Cancer Mortality Population United ...
Jul, 2018... ? 1. Comprehensive analysis of global as well as regional markets of non-small cell lung cancer therapeutics market. 2. Complete coverage of all the segments in non-small cell lung cancer therapeutics market to analyze the trends, developments in the ...
Jun, 2018 100 pages... on the cost and reimbursement of novel cancer gene therapies. SCOPE GlobalData’s Gene Therapy in Oncology combines KOL and payer insight with in-house analyst ... what are the currently marketed gene therapies in the oncology space in the 8MM. Clinical Development of Gene Therapies in Oncology: What are the late ...
Jun, 2018 145 pages... Cancer Gene Therapy market size will grow from USD XX Million in 2017 to USD XX Million by 2023, ... , and the market size is projected from 2018 to 2023. By Market Players: Adaptimmune, GlaxoSmithKline, Bluebird ... in detail. Data and information by manufacturer, by region, by type, by application and etc, and ...
Jul, 2018 160 pages... .com provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses ... of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, ...
Jun, 2018 80 pages... identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the ... universe of laboratories performing cancer diagnostic testing by country. Cancer statistics, etiology and recent developments in Europe. Business Opportunities and Strategic ...
Jun, 2018 820 pages... and the market size is projected from 2018 to 2023. By Market Players: Accuray Inc., Koninklijke ... and Maintenance Services, By Application Hospitals, Oncology Clinics, Government Institutions, Research Centers, ... in detail. Data and information by manufacturer, by region, by type, by application and etc, and ...
Jun, 2018 133 pagesThe global ovarian cancer drugs market size is expected to be valued at USD 4.5 billion by 2022, as per a new report by Grand ... to be the upcoming milestones for ovarian cancer treatment PARP inhibitors are anticipated to be the fastest growing drug class in the ovarian cancer market through the forecast period ...
May, 2018 94 pages... Report The report entitled “China Cancer Drug Market: Size, Trends & Forecasts (2018-2022)”, provides analysis of the China cancer drug market, with detailed analysis of market size and growth, and value ...
Jun, 2018 70 pages... suggests alternative business expansion strategies for suppliers.strong> RationaleThe cancer diagnostics market is on the verge of explosion, as the researchers ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...
Jun, 2018 820 pages... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...
Jun, 2018 1200 pages... emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets; reviews current and ... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers ...
Jun, 2018 620 pages... emerging in the cancer diagnostics market during the next five years. The report examines trends in the UK cancer diagnostics markets; reviews current and ... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers ...
Jun, 2018 565 pages... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...
Jun, 2018 565 pages... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...
Jun, 2018 590 pages... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...
Jun, 2018 570 pages... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...
Jun, 2018 585 pages... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...
Jun, 2018 585 pages... Cancer Diagnostic Market & Forecast, By Test Type (Pap smear and HPV DNA), Countries (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway and Netherlands)” provides a complete analysis of Europe Cervical Cancer Screening Market. The covers European Countries Cervical Cancer Test Market ...
Jun, 2018... cancer test market in the developing countries. Renub Research report titled “Asia Cervical Cancer Diagnostic Market, By Test Type (Pap smear, HPV DNA and VIA), Countries (Japan, Korea, Singapore, Malaysia, India, China, Thailand and Indonesia) & Forecast” provides a complete analysis of Asia Cervical Cancer ...
Jun, 2018... play a role? Twelve of the world’s leading KOLs from the US and Europe offer candid insights on four marketed therapies and nine Phase ... ? Could ImmunoGen’s antibody-drug conjugate IMGN853 have a potential role in ovarian cancer? KOLs debate the potential advantages and pitfalls to this novel approach ...
Apr, 2018... the Non-small Cell Lung Cancer Therapeutics market challenges to market growth? 10. What are the Non-small Cell Lung Cancer Therapeutics market opportunities and threats faced by the vendors in the global Non-small Cell Lung Cancer ...
Jul, 2018 150 pagesOcular Cancer Drug Development Pipeline Review, 2018 SUMMARY This report provides an overview of the pipeline landscape for ocular cancer and comprehensive information on the therapeutics under development and key players ...
May, 2018 63 pages... ; and diagnosed incident cases of pancreatic cancer (excluding PNETs) by KRAS mutations. The pancreatic cancer epidemiology forecast report is written and developed by ... disease trends in the 7MM. REASONS TO BUY The Pancreatic Cancer Epidemiology Forecast report will allow you to - Develop business strategies ...
Apr, 2018 42 pages... growth over the next decade (2016-2026). SCOPE GlobalData’s Colorectal Cancer: Competitive Landscape to 2026 combines data from the Pharma Intelligence Center with ...
Apr, 2018 53 pagesBreast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence SUMMARY Breast cancer is the second most common cancer ... , Kadcyla, Perjeta and Kisqali. SCOPE The breast cancer Asia-Pacific market will be valued at $4.75 billion in ...
May, 2018 215 pages... current report. This report includes market estimates for breast cancer diagnostics (mammography, biopsy and companion diagnostics), therapeutics along with market share of therapeutics by drug class (HER2 inhibitors, mitotic ...
May, 2018 154 pagesThis report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing. Contains 25 pages
May, 2018 25 pages... , biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics ...
May, 2018 110 pages... reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing. ... presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products, including their sales, product portfolios, distribution tactics ...
May, 2018 119 pagesGlobal Radiation Oncology Market – Drivers, Restraints, Opportunities, Trends, and Forecasts: 2018–2024 Overview: Radiation oncology is a medical specialty that uses high energy radiation ... healthcare awareness among the public. Market Analysis: The “Global Radiation Oncology” market is estimated to witness a ...
103 pages... are some of the factors hampering the market growth to an extent. Market Analysis: The “Global Cancer Diagnostics Market” is estimated to witness a CAGR ... The global cancer diagnostics market by application is segmented into lung cancer, breast cancer, Colorectal cancer, prostate cancer and others. Lung cancer ...
Dec, 2017 118 pages... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...
Apr, 2018 229 pages... 's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2018' provides an overview of Non-Small Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Non-Small Cell Lung Cancer. Report includes an overview of trial ...
Mar, 2018 3085 pages... REPORT DELIVERS? 1. Comprehensive analysis of global as well as regional markets of oncology biosimilars market. 2. Complete coverage of all the segments in oncology biosimilars market to analyze the trends, developments in the global ...
Mar, 2018 100 pages... The global lung cancer therapeutics market is segmented on the basis of type of molecule and disease type. Global Lung Cancer Therapeutics Market by Type of Molecule Small Molecules Biologics Global Lung Cancer Therapeutics Market by Disease ...
Mar, 2018 100 pages... type. Global Gastric Cancer Drugs Market by Route of Administration Oral Parenteral Global Gastric Cancer Drugs Market by Lines of Chemotherapy First-Line Chemotherapy Second-Line Chemotherapy Global Gastric Cancer Drugs Market by Molecule Type ...
Mar, 2018 100 pages